{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:38:59Z","timestamp":1784835539926,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H05090"],"award-info":[{"award-number":["16H05090"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H05502"],"award-info":[{"award-number":["18H05502"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07311"],"award-info":[{"award-number":["18K07311"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17cm0106522j0002"],"award-info":[{"award-number":["JP17cm0106522j0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,5,7]]},"DOI":"10.1038\/s41388-020-1253-0","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T12:02:39Z","timestamp":1584014559000},"page":"3867-3878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells"],"prefix":"10.1038","volume":"39","author":[{"given":"Norihito","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobumichi","family":"Ohoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genichiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Demizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-7718","authenticated-orcid":false,"given":"Keiji","family":"Miyawaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8695-9025","authenticated-orcid":false,"given":"Kumiko","family":"Ui-Tei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-1337","authenticated-orcid":false,"given":"Mikihiko","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1126\/science.144.3623.1229","volume":"144","author":"CT Rudkin","year":"1964","unstructured":"Rudkin CT, Hungerford DA, Nowell PC. DNA contents of chromosome Ph1 and chromosome 21 in human chronic granulocytic leukemia. Science. 1964;144:1229\u201331.","journal-title":"Science"},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290\u20133.","journal-title":"Nature"},{"key":"1253_CR3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0092-8674(84)90438-0","volume":"37","author":"JB Konopka","year":"1984","unstructured":"Konopka JB, Watanabe SM, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 1984;37:1035\u201342.","journal-title":"Cell"},{"key":"1253_CR4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/315758a0","volume":"315","author":"N Heisterkamp","year":"1985","unstructured":"Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G. Structural organization of the bcr gene and its role in the Ph\u2019 translocation. Nature. 1985;315:758\u201361.","journal-title":"Nature"},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985;315:550\u20134.","journal-title":"Nature"},{"key":"1253_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1609324","volume":"376","author":"A Hochhaus","year":"2017","unstructured":"Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, et al. Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med. 2017;376:917\u201327.","journal-title":"N Engl J Med"},{"key":"1253_CR7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1158\/1078-0432.CCR-13-1283","volume":"20","author":"V Gandhi","year":"2014","unstructured":"Gandhi V, Plunkett W, Cortes JE. Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia. Clin Cancer Res. 2014;20:1735\u201340.","journal-title":"Clin Cancer Res"},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1634\/theoncologist.2013-0077","volume":"19","author":"F Alvandi","year":"2014","unstructured":"Alvandi F, Kwitkowski VE, Ko CW, Rothmann MD, Ricci S, Saber H, et al. U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia. Oncologist. 2014;19:94\u20139.","journal-title":"Oncologist"},{"key":"1253_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0805-1","volume":"17","author":"M Massimino","year":"2018","unstructured":"Massimino M, Stella S, Tirro E, Romano C, Pennisi MS, Puma A, et al. Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia. Mol Cancer. 2018;17:56.","journal-title":"Mol Cancer"},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood-2006-10-054098","volume":"110","author":"C Peng","year":"2007","unstructured":"Peng C, Brain J, Hu Y, Goodrich A, Kong L, Grayzel D, et al. Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells. Blood. 2007;110:678\u201385.","journal-title":"Blood"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.4161\/cc.6.18.4722","volume":"6","author":"C Peng","year":"2007","unstructured":"Peng C, Li D, Li S. Heat shock protein 90: a potential therapeutic target in leukemic progenitor and stem cells harboring mutant BCR-ABL resistant to kinase inhibitors. Cell Cycle. 2007;6:2227\u201331.","journal-title":"Cell Cycle"},{"key":"1253_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/anie.201507634","volume":"55","author":"AC Lai","year":"2016","unstructured":"Lai AC, Toure M, Hellerschmied D, Salami J, Jaime-Figueroa S, Ko E, et al. Modular PROTAC design for the degradation of oncogenic BCR-ABL. Angew Chem Int Ed Engl. 2016;55:807\u201310.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1253_CR13","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1016\/j.bmcl.2016.09.041","volume":"26","author":"Y Demizu","year":"2016","unstructured":"Demizu Y, Shibata N, Hattori T, Ohoka N, Motoi H, Misawa T, et al. Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand. Bioorg Med Chem Lett. 2016;26:4865\u20139.","journal-title":"Bioorg Med Chem Lett"},{"key":"1253_CR14","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/cas.13284","volume":"108","author":"N Shibata","year":"2017","unstructured":"Shibata N, Miyamoto N, Nagai K, Shimokawa K, Sameshima T, Ohoka N, et al. Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. Cancer Sci. 2017;108:1657\u201366.","journal-title":"Cancer Sci"},{"key":"1253_CR15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1021\/acsmedchemlett.7b00247","volume":"8","author":"K Shimokawa","year":"2017","unstructured":"Shimokawa K, Shibata N, Sameshima T, Miyamoto N, Ujikawa O, Nara H, et al. Targeting the allosteric site of oncoprotein BCR-ABL as an alternative strategy for effective target protein degradation. ACS Med Chem Lett. 2017;8:1042\u20137.","journal-title":"ACS Med Chem Lett"},{"key":"1253_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31913-5","volume":"8","author":"N Shibata","year":"2018","unstructured":"Shibata N, Shimokawa K, Nagai K, Ohoka N, Hattori T, Miyamoto N, et al. Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase. Sci Rep. 2018;8:13549.","journal-title":"Sci Rep"},{"key":"1253_CR17","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1158\/0008-5472.CAN-14-1211","volume":"74","author":"A Pal","year":"2014","unstructured":"Pal A, Young MA, Donato NJ. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer. Cancer Res. 2014;74:4955\u201366.","journal-title":"Cancer Res"},{"key":"1253_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17:57\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"1253_CR19","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1182\/blood-2009-10-249623","volume":"116","author":"F Tsukahara","year":"2010","unstructured":"Tsukahara F, Maru Y. Bag1 directly routes immature BCR-ABL for proteasomal degradation. Blood. 2010;116:3582\u201392.","journal-title":"Blood"},{"key":"1253_CR20","doi-asserted-by":"publisher","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","volume":"85","author":"GQ Daley","year":"1988","unstructured":"Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein. Proc Natl Acad Sci USA. 1988;85:9312\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1253_CR21","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.chembiol.2011.08.018","volume":"18","author":"M Altun","year":"2011","unstructured":"Altun M, Kramer HB, Willems LI, McDermott JL, Leach CA, Goldenberg SJ, et al. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem Biol. 2011;18:1401\u201312.","journal-title":"Chem Biol"},{"key":"1253_CR22","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-15-1544","volume":"75","author":"AP Lawson","year":"2015","unstructured":"Lawson AP, Long MJC, Coffey RT, Qian Y, Weerapana E, El Oualid F, et al. Naturally occurring isothiocyanates exert anticancer effects by inhibiting deubiquitinating enzymes. Cancer Res. 2015;75:5130\u201342.","journal-title":"Cancer Res"},{"key":"1253_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep45037","volume":"7","author":"K Kawaguchi","year":"2017","unstructured":"Kawaguchi K, Uo K, Tanaka T, Komada M. Tandem UIMs confer Lys48 ubiquitin chain substrate preference to deubiquitinase USP25. Sci Rep. 2017;7:45037.","journal-title":"Sci Rep"},{"key":"1253_CR24","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1074\/jbc.M113.528372","volume":"289","author":"H Tanno","year":"2014","unstructured":"Tanno H, Shigematsu T, Nishikawa S, Hayakawa A, Denda K, Tanaka T, et al. Ubiquitin-interacting motifs confer full catalytic activity, but not ubiquitin chain substrate specificity, to deubiquitinating enzyme USP37. J Biol Chem. 2014;289:2415\u201323.","journal-title":"J Biol Chem"},{"key":"1253_CR25","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1093\/emboj\/cdf562","volume":"21","author":"A Klejman","year":"2002","unstructured":"Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE, et al. The Src family kinase Hck couples BCR\/ABL to STAT5 activation in myeloid leukemia cells. EMBO J. 2002;21:5766\u201374.","journal-title":"EMBO J"},{"key":"1253_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.exphem.2010.04.017","volume":"38","author":"S Okabe","year":"2010","unstructured":"Okabe S, Tauchi T, Ohyashiki K. Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutation. Exp Hematol. 2010;38:765\u201372.","journal-title":"Exp Hematol"},{"key":"1253_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005571","volume":"4","author":"A Denuc","year":"2009","unstructured":"Denuc A, Bosch-Comas A, Gonzalez-Duarte R, Marfany G. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS One. 2009;4:e5571.","journal-title":"PLoS One"},{"key":"1253_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.201112098","volume":"196","author":"KJ Roux","year":"2012","unstructured":"Roux KJ, Kim DI, Raida M, Burke B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol. 2012;196:801\u201310.","journal-title":"J Cell Biol"},{"key":"1253_CR29","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1110\/ps.04911804","volume":"13","author":"E Choi-Rhee","year":"2004","unstructured":"Choi-Rhee E, Schulman H, Cronan JE. Promiscuous protein biotinylation by Escherichia coli biotin protein ligase. Protein Sci. 2004;13:3043\u201350.","journal-title":"Protein Sci"},{"key":"1253_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jnutbio.2005.03.017","volume":"16","author":"JE Cronan","year":"2005","unstructured":"Cronan JE. Targeted and proximity-dependent promiscuous protein biotinylation by a mutant Escherichia coli biotin protein ligase. J Nutr Biochem. 2005;16:416\u20138.","journal-title":"J Nutr Biochem"},{"key":"1253_CR31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/embor.2009.192","volume":"10","author":"R Hjerpe","year":"2009","unstructured":"Hjerpe R, Aillet F, Lopitz-Otsoa F, Lang V, England P, Rodriguez MS. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 2009;10:1250\u20138.","journal-title":"EMBO Rep."},{"key":"1253_CR32","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1021\/acschembio.7b00334","volume":"12","author":"JD Wrigley","year":"2017","unstructured":"Wrigley JD, Gavory G, Simpson I, Preston M, Plant H, Bradley J, et al. Identification and characterization of dual inhibitors of the USP25\/28 deubiquitinating enzyme subfamily. ACS Chem Biol. 2017;12:3113\u201325.","journal-title":"ACS Chem Biol"},{"key":"1253_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10549-006-9393-7","volume":"104","author":"S Deng","year":"2007","unstructured":"Deng S, Zhou H, Xiong R, Lu Y, Yan D, Xing T, et al. Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics. Breast Cancer Res Treat. 2007;104:21\u201330.","journal-title":"Breast Cancer Res Treat"},{"key":"1253_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-166","volume":"13","author":"J Li","year":"2014","unstructured":"Li J, Tan Q, Yan M, Liu L, Lin H, Zhao F, et al. miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. Mol Cancer. 2014;13:166.","journal-title":"Mol Cancer"},{"key":"1253_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.molcel.2019.02.029","volume":"74","author":"F Sauer","year":"2019","unstructured":"Sauer F, Klemm T, Kollampally RB, Tessmer I, Nair RK, Popov N, et al. Differential oligomerization of the deubiquitinases USP25 and USP28 regulates their activities. Mol Cell. 2019;74:421\u201335 e410.","journal-title":"Mol Cell"},{"key":"1253_CR36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1101\/gad.300889.117","volume":"31","author":"D Xu","year":"2017","unstructured":"Xu D, Liu J, Fu T, Shan B, Qian L, Pan L, et al. USP25 regulates Wnt signaling by controlling the stability of tankyrases. Genes Dev. 2017;31:1024\u201335.","journal-title":"Genes Dev"},{"key":"1253_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2004.05.010","volume":"216","author":"S Gelmini","year":"2004","unstructured":"Gelmini S, Poggesi M, Distante V, Bianchi S, Simi L, Luconi M, et al. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett. 2004;216:81\u20137.","journal-title":"Cancer Lett"},{"key":"1253_CR38","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nature08356","volume":"461","author":"SM Huang","year":"2009","unstructured":"Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 2009;461:614\u201320.","journal-title":"Nature"},{"key":"1253_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.celrep.2015.09.014","volume":"13","author":"W Wang","year":"2015","unstructured":"Wang W, Li N, Li X, Tran MK, Han X, Chen J. Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins. Cell Rep. 2015;13:524\u201332.","journal-title":"Cell Rep"},{"key":"1253_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ncb1601","volume":"9","author":"N Popov","year":"2007","unstructured":"Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol. 2007;9:765\u201374.","journal-title":"Nat Cell Biol"},{"key":"1253_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07510-5","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu B, Sureda-Gomez M, Zhen Y, Amador V, Reverter D. A quaternary tetramer assembly inhibits the deubiquitinating activity of USP25. Nat Commun. 2018;9:4973.","journal-title":"Nat Commun"},{"key":"1253_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.molcel.2019.02.030","volume":"74","author":"M Gersch","year":"2019","unstructured":"Gersch M, Wagstaff JL, Toms AV, Graves B, Freund SMV, Komander D. Distinct USP25 and USP28 oligomerization states regulate deubiquitinating activity. Mol Cell. 2019;74:436\u201351 e437.","journal-title":"Mol Cell"},{"key":"1253_CR43","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644\u20138.","journal-title":"Science"},{"key":"1253_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561\u20136.","journal-title":"Nature"},{"key":"1253_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nm.2644","volume":"18","author":"T Kohno","year":"2012","unstructured":"Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, et al. KIF5B-RET fusions in lung adenocarcinoma. Nat Med. 2012;18:375\u20137.","journal-title":"Nat Med"},{"key":"1253_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm.2658","volume":"18","author":"K Takeuchi","year":"2012","unstructured":"Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med. 2012;18:378\u201381.","journal-title":"Nat Med"},{"key":"1253_CR47","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm.2673","volume":"18","author":"D Lipson","year":"2012","unstructured":"Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med. 2012;18:382\u20134.","journal-title":"Nat Med"},{"key":"1253_CR48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0145-2126(85)90060-8","volume":"9","author":"K Kishi","year":"1985","unstructured":"Kishi K. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res. 1985;9:381\u201390.","journal-title":"Leuk Res"},{"key":"1253_CR49","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/nar\/gkh247","volume":"32","author":"K Ui-Tei","year":"2004","unstructured":"Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 2004;32:936\u201348.","journal-title":"Nucleic Acids Res"},{"key":"1253_CR50","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/leu.2017.36","volume":"31","author":"S Reckel","year":"2017","unstructured":"Reckel S, Hamelin R, Georgeon S, Armand F, Jolliet Q, Chiappe D, et al. Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics. Leukemia. 2017;31:1502\u201312.","journal-title":"Leukemia"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1253-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:37Z","timestamp":1684617637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-1253-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":50,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,5,7]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-1253-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"6 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}